{"": [81, 1217, 0, 1218, 1239, 0, 1240, 1372, 0, 1373, 2779, 0, 2780, 3738, 0, 3739, 5092, 0], "Identification of broadly reactive mAbs from COVID-19 convalescent donors": [5093, 8993, 0], "COV44-62 and COV44-79 broadly neutralize coronaviruses": [8994, 9936, 0], "Broadly reactive mAbs target the coronavirus fusion peptide": [9937, 15553, 0], "Crystal structures of anti-fusion peptide antibodies": [15554, 18728, 0], "Response to the fusion peptide following COVID-19 vaccination and infection": [18729, 20420, 0], "COV44-62 and COV44-79 inhibit membrane fusion": [20421, 20830, 0], "COV44-79 limits disease in the Syrian hamster model": [20831, 22739, 0], "Discussion": [22740, 27214, 0], "Study participants": [27238, 29251, 0], "Coronavirus spike proteins": [29252, 32577, 0], "Generation of multiplexed CoV antigen beads": [32578, 33697, 0], "Plasma IgG reactivity to human coronaviruses and donor selection": [33698, 34729, 0], "Memory B cell isolation from PBMCs": [34730, 35348, 0], "Optofluidic-based isolation of individual cross-reactive antibody secreting B cells": [35349, 37548, 0], "mAb sequence analysis and expression": [37549, 38517, 0], "HLA typing for donor identification": [38518, 39975, 0], "Recombinant mAb binding to coronavirus antigens": [39976, 40667, 0], "Phylogenetic tree generation": [40668, 41232, 0], "Sequence conservation": [41233, 42909, 0], "SARS-CoV-2 spike and S2 subunit epitope binning by SPR": [42910, 44150, 0], "SARS-CoV-2 S2 binding kinetics with Fab fragments of cross-reactive antibodies": [44151, 45294, 0], "SARS-CoV-2 S2 peptide mapping": [45295, 46383, 0], "Cell-cell fusion inhibition assay": [46384, 47857, 0], "Shotgun mutagenesis epitope mapping of antibodies by alanine scanning": [47858, 50028, 0], "Expression and purification of Fabs for structural studies": [50029, 50809, 0], "Crystallization and structural determination": [50810, 52949, 0], "Authentic OC43-CoV-GFP virus propagation and neutralization assay": [52950, 54799, 0], "Pseudovirus production and neutralization assays (AssayNIH)": [54800, 56444, 0], "Pseudovirus production and neutralization assays (AssayScripps)": [56445, 58426, 0], "Hamsterization of human monoclonal antibodies": [58427, 58868, 0], "Syrian hamster efficacy studies": [58869, 60463, 0], "Animal ethics statement": [60464, 61048, 0], "Vaccinee and convalescent plasma binding to peptides": [61049, 61766, 0], "Statistical analyses": [61767, 62655, 0], "Materials and Methods": [27215, 62655, 1], "Supplementary Material": [62656, 62682, 0]}